Transarterial chemoembolization in a patient with recurrent hepatocellular carcinoma and portal vein thrombosis: A case report and review of the literature

Ailawadhi Sikander, Shenoy Sadashiv, Sham Ronald, Javle Milind

Research output: Contribution to journalReview article

5 Scopus citations


Primary hepatocellular carcinoma (HCC) accounts for more than 5% of all cancers in the world, and causes between 250,000 and one million deaths globally each year. The incidence of portal vein thrombosis in HCC patients is around 8%. These patients are regarded as unsuitable for chemoembolization, especially if there is portal vein occlusion. The authors describe a patient with HCC and partial portal vein thrombosis who successfully underwent transarterial chemoembolization.

Original languageEnglish (US)
Pages (from-to)638-639
Number of pages2
JournalAmerican Journal of Clinical Oncology: Cancer Clinical Trials
Issue number6
StatePublished - Dec 1 2005



  • Chemoembolization
  • Hepatocellular carcinoma
  • Portal vein thrombosis

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this